Literature DB >> 17175220

Effects of tolerance induction on the actions of interferon-gamma on porcine cardiac allografts.

R Hoerbelt1, L C Benjamin, T Shoji, D R Johnston, A Muniappan, D A Guenther, J S Allan, S L Houser, J C Madsen.   

Abstract

It is well known that interferon-gamma (IFN-gamma) not only plays a critical role in antigen-dependent but also in antigen-independent tissue injury; however, it is not clear how tolerance induction affects the actions of IFN-gamma in the transplant setting. To address this question, we compared the effects of IFN-gamma on porcine recipients of near-syngeneic, rejecting, and tolerant heart transplants. IFN-gamma was infused continuously into the left anterior descending artery of hearts transplanted into 3 groups of major histocompatibility complex (MHC) inbred miniature swine, each treated with a 12-day course of cyclosporine A (CyA). Group 1 recipients received a MHC class I disparate heart, group 2 recipients received a near-syngeneic heart, and group 3 recipients were cotransplanted with a MHC class I disparate heart and kidney, which uniformly induces tolerance to both grafts. An additional group of animals was not transplanted but received intracoronary IFN-gamma infusion into their native hearts. IFN-gamma perfusion not only accelerated the acute rejection of MHC class I disparate hearts (mean survival time = 19 +/- 7.21 vs 38 +/- 8.19 days, P = .025), but caused near-syngeneic heart transplants, which otherwise survive indefinitely, to reject within 35 days (n = 3). In contrast, IFN-gamma perfusion had no demonstrable effects on interstitial rejection, the development of vascular lesions, or graft survival in tolerant heart plus kidney allograft recipients (n = 4) or in autologous hearts (n = 2). These results suggest that tolerance induction mitigates the damaging effects of IFN-gamma itself and that the beneficial effects of tolerance induction on acute and chronic rejection may extend to antigen-independent factors like ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17175220      PMCID: PMC1828072          DOI: 10.1016/j.transproceed.2006.10.119

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

1.  Mechanisms of tolerance induction in the heart/kidney model in miniature swine.

Authors:  J D. Mezrich; K Yamada; R S. Lee; K Mawulawde; S L. Houser; M L. Schwarze; M E. Maloney; H C. Amoah; E P. Pillsbury; D H. Sachs; J C. Madsen
Journal:  J Heart Lung Transplant       Date:  2001-02       Impact factor: 10.247

2.  Histocompatible miniature swine: an inbred large-animal model.

Authors:  Joshua D Mezrich; Gary W Haller; J Scott Arn; Stuart L Houser; Joren C Madsen; David H Sachs
Journal:  Transplantation       Date:  2003-03-27       Impact factor: 4.939

3.  Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.

Authors:  Tarek El-Sawy; Masayoshi Miura; Robert Fairchild
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine.

Authors:  J C Madsen; K Yamada; J S Allan; J K Choo; A E Erhorn; M R Pins; L Vesga; J K Slisz; D H Sachs
Journal:  Transplantation       Date:  1998-02-15       Impact factor: 4.939

6.  Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.

Authors:  C H Chang; S Guerder; S C Hong; W van Ewijk; R A Flavell
Journal:  Immunity       Date:  1996-02       Impact factor: 31.745

7.  IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway.

Authors:  C M Snapper; F Rosas; M A Moorman; L Jin; K Shanebeck; D M Klinman; M R Kehry; J J Mond; C R Maliszewski
Journal:  Int Immunol       Date:  1996-06       Impact factor: 4.823

8.  Molecular identification of porcine interleukin 10: regulation of expression in a kidney allograft model.

Authors:  G Blancho; P Gianello; S Germana; M Baetscher; D H Sachs; C LeGuern
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes.

Authors:  E Braakman; A van Tunen; A Meager; C J Lucas
Journal:  Cell Immunol       Date:  1986-05       Impact factor: 4.868

10.  Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.

Authors:  K E Cole; C A Strick; T J Paradis; K T Ogborne; M Loetscher; R P Gladue; W Lin; J G Boyd; B Moser; D E Wood; B G Sahagan; K Neote
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

  10 in total
  1 in total

1.  Oxazolone-induced delayed type hypersensitivity reaction in the adult yucatan pigs. A useful model for drug development and validation.

Authors:  Samer Nuhaily; Bassam B Damaj; Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2009-08-21       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.